August 25, 2010
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

August 20, 2010
Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Corporate News Release

Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference

06/11/07

BELLEVILLE, ON, Nov. 6 - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that Cameron Groome, Executive Vice-President, Corporate & Strategic Development, will present at the Rodman & Renshaw 9th Annual Global Healthcare Conference in New York City tomorrow. Mr. Groome will present at 8:30 a.m. (Eastern Time) in the Holmes II Room of the New York Palace Hotel.

A live webcast of Bioniche's presentation can be accessed here . A replay of the presentation will be archived for 90 days after the conference. For more information about the Rodman & Renshaw 9th Annual Healthcare Conference, please visit this link.

Back

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Food Safety
Human Health